SCHEMBL27680770

SCHEMBL27680770

CC(C)(CCC1CNC1)OC(N)=O

nearest known ligand 0.33

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.31
▸ HSD17B10 Q99714 1/20 0.31
▸ GAA P10253 1/20 0.31
▸ ATM Q13315 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27615588 0.84 KMT2A (0.42) LMNAATM
SCHEMBL27896511 0.84 HTR4 (0.36) —
SCHEMBL28664534 0.84 LMNA (0.32) LMNAHSD17B10ATM
SCHEMBL27593048 0.81 LMNA (0.40) LMNAHSD17B10
SCHEMBL27593232 0.81 LMNA (0.30) LMNAHSD17B10
SCHEMBL27611213 0.81 LMNA (0.40) LMNAHSD17B10
SCHEMBL28097052 0.81 CHRM2 (0.30) LMNAHSD17B10
SCHEMBL27593046 0.81 LMNA (0.40) LMNAHSD17B10
SCHEMBL3603125 0.81 CHRM2 (0.33) LMNAHSD17B10
SCHEMBL27593039 0.81 NR1H2 (0.37) LMNAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101128199-B Monocyclic heterocycles as kinase inhibitors BRISTOL MYERS SQUIBB CO 2013-07-24 — — CN disclosed
CN-101426486-A Compounds for the treatment of inflammatory disorders and microbial diseases SCHERING CORP (US) 2009-05-06 — — CN disclosed
CN-101128199-A Monocyclic heterocycles as kinase inhibitors BRISTOL MYERS SQUIBB CO (US) 2008-02-20 — — CN disclosed
CN-101027295-A Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders SCHERING CORP (US) 2007-08-29 — — CN disclosed
Send feedback